Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

View:
Post by biofool on Oct 27, 2022 1:03pm

Who is

behind the BexCaFe Arrangement?

Is sirona just a shell that has served its purpose and now the fruits are being reaped elsewhere?

any thoughts? get out into the industry and find out!
Comment by SironaInvestor on Oct 28, 2022 9:05am
I'm pretty sure that Sirona failed again here as Elanco decided to contract with another party. But as we all know, Howard will find something new with unmet need which brings him a smile in his bloody face again. :-) Guys, we all have lost and made ourselves the wrong Due diligence. This company with the inexperienced Canadian Management will survive, I'm pretty sure, but the hundreds of ...more  
Comment by biorun on Oct 28, 2022 9:23am
You seem to be the perfect candidate to sell your shares to someone else who sees it differently. There are 4 other major players listed in this space, all which dwarf this Elanco by billions and billions.  If Elanco is moving forward, and the company who looks to be partnering with them (Theracos) and it looks like they set up a shell company to move the deal forward with Elanco very ...more  
Comment by SironaInvestor on Oct 28, 2022 10:07am
Biorun, or should I say Howard, Chris or maybe Michelle. You are trying to push this bloody stock every day. No chance or voice for you anymore.
Comment by biorun on Oct 28, 2022 11:11am
I am not any of these people but there needs to be some space for other perspectives other than those that constantly put management and everything related down. Sorry, but you are not going to filter me on what I believe to be true or not. Whether you take in my comments or not is really none of my business. Why don't you offer something of value to the discussion instead of feeding false ...more  
Comment by SironaInvestor on Oct 28, 2022 12:28pm
Banal question: Why is Howard not offering a Q&A?? Why?? Give me one Reason. It would be so easy to get current shareholders relaxed when Howard offering facts??? He's not doing it? What do you think is the rationale behind?? Any guess??
Comment by bealert on Oct 28, 2022 1:17pm
SironaInvestor, just read this statement and you will know why you ain't hearin nothin: RE:RE:Corp Secrets being held at gunpoint tighter that a Gnatsarse Somebody else earlier said it too, about non-disclosure. Alergan is TOTALLY in charge of the deal, hence Sirona not allowed to disclose anything that Alergan didn't want them too.  They are big enough that Sirona doesn't ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities